Notice: This company has been marked as potentially delisted and may not be actively trading. AVROBIO (AVRO) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends AVROBIO Short Interest DataAVROBIO (AVRO) has a short interest of 139,600 shares, representing 0.35% of the float (the number of shares available for trading by the public). This marks a -23.13% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 269,831 shares to cover all short positions.Current Short Interest139,600 sharesPrevious Short Interest181,600 sharesChange Vs. Previous Month-23.13%Dollar Volume Sold Short$206,608.00Short Interest Ratio0.6 Days to CoverLast Record DateMay 31, 2024Outstanding Shares44,890,000 sharesFloat Size39,430,000 sharesShort Percent of Float0.35%Today's Trading Volume206,800 sharesAverage Trading Volume269,831 sharesToday's Volume Vs. Average77% Short Selling AVROBIO? Sign up to receive the latest short interest report for AVROBIO and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAVRO Short Interest Over TimeAVRO Days to Cover Over TimeAVRO Percentage of Float Shorted Over Time Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide AVROBIO Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/2024139,600 shares $206,608.00 -23.1%0.4%0.6 $1.48 5/15/2024181,600 shares $248,792.00 +11.3%0.5%0.8 $1.37 4/30/2024163,200 shares $194,208.00 +19.0%0.4%0.8 $1.19 4/15/2024137,200 shares $172,872.00 -4.2%0.4%0.5 $1.26 3/31/2024143,200 shares $183,296.00 +14.6%0.4%0.5 $1.28 3/15/2024125,000 shares $162,500.00 +3.1%0.3%0.4 $1.30 Get the Latest News and Ratings for AVRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AVROBIO and its competitors with MarketBeat's FREE daily newsletter. 2/29/2024121,200 shares $158,772.00 -4.2%0.3%0.4 $1.31 2/15/2024126,500 shares $165,715.00 -30.3%0.3%0.4 $1.31 1/31/2024181,500 shares $228,690.00 -61.8%0.5%0.5 $1.26 1/15/2024474,600 shares $669,186.00 -29.2%1.2%1.8 $1.41 12/31/2023670,400 shares $911,744.00 -5.8%1.8%2.4 $1.36 12/15/2023711,700 shares $967,912.00 -22.6%1.9%2.5 $1.36 11/30/2023919,000 shares $1.21 million -4.8%2.4%2.8 $1.32 11/15/2023964,900 shares $1.29 million -58.2%2.5%2.8 $1.34 10/31/20232,310,000 shares $3.67 million +2.7%6.0%6.5 $1.59 10/15/20232,250,000 shares $3.51 million +7.1%5.8%5.6 $1.56 9/30/20232,100,000 shares $3.23 million +21.4%5.4%2.1 $1.54 9/15/20231,730,000 shares $2.70 million -2.3%4.5%1.6 $1.56 8/31/20231,770,000 shares $2.69 million -18.4%4.6%1.5 $1.52 8/15/20232,170,000 shares $3.30 million +6.4%5.6%0.8 $1.52 7/31/20232,040,000 shares $3.16 million -15.0%5.5%0.7 $1.55 7/15/20232,400,000 shares $3.38 million +79.1%6.4%0.8 $1.41 6/30/20231,340,000 shares $1.27 million -10.1%3.6%0.6 $0.95 6/15/20231,490,000 shares $1.65 million +4.9%4.0%0.7 $1.11 5/31/20231,420,000 shares $1.56 million +44.4%3.8%0.7 $1.10 5/15/2023983,300 shares $609,547.67 +0.8%2.6%0.5 $0.62 4/30/2023975,800 shares $974,238.72 -5.3%2.6%0.8 $1.00 4/15/20231,030,000 shares $971,290.00 -6.4%2.8%0.8 $0.94 3/31/20231,100,000 shares $1.10 million +86.5%3.0%0.9 $1.00 3/15/2023589,700 shares $725,331.00 +39.0%1.6%0.5 $1.23 2/28/2023424,200 shares $593,880.00 -43.7%1.1%0.3 $1.40 2/15/2023753,500 shares $1.18 million +504.7%2.0%0.6 $1.56 1/31/2023124,600 shares $113,386.00 -6.0%0.3%0.1 $0.91 1/15/2023132,500 shares $119,250.00 +2.3%0.4%0.4 $0.90 12/30/2022129,500 shares $92,320.55 -37.7%0.4%0.4 $0.71 12/15/2022207,800 shares $164,639.94 -32.0%0.6%0.6 $0.79 11/30/2022305,700 shares $277,850.73 +21.1%0.8%0.9 $0.91 11/15/2022252,500 shares $188,844.75 -17.6%0.7%0.8 $0.75 10/31/2022306,300 shares $208,406.52 +7.1%0.8%1.1 $0.68 10/15/2022286,000 shares $167,281.40 +1.5%0.8%1 $0.58Trump’s Back, but DC’s Coming for Your Money! (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov 9/30/2022281,800 shares $181,056.50 -3.0%0.8%1 $0.64 9/15/2022290,500 shares $248,203.20 +13.4%0.8%0.9 $0.85 8/31/2022256,200 shares $243,390.00 -15.3%0.7%0.8 $0.95 8/15/2022302,300 shares $335,553.00 -25.7%0.8%0.8 $1.11 7/31/2022406,700 shares $370,259.68 -10.1%1.1%1 $0.91 7/15/2022452,300 shares $431,946.50 -3.9%1.2%1 $0.96 6/30/2022470,400 shares $432,768.00 -72.2%1.5%1 $0.92 6/15/20221,690,000 shares $1.53 million -7.7%5.2%3.3 $0.91 5/31/20221,830,000 shares $1.78 million +4.0%5.7%4.4 $0.97 5/15/20221,760,000 shares $1.42 million +5.4%5.4%4.3 $0.81 4/30/20221,670,000 shares $1.54 million +18.4%4.5%2.9 $0.92 4/15/20221,410,000 shares $1.61 million +7.6%3.8%2.4 $1.14 3/31/20221,310,000 shares $1.73 million +1.6%3.6%1.8 $1.32 3/15/20221,290,000 shares $1.79 million +6.6%3.5%1.6 $1.39 2/28/20221,210,000 shares $1.75 million +11.0%3.3%1.5 $1.45 2/15/20221,090,000 shares $1.81 million +6.9%3.0%1.2 $1.66 1/31/20221,020,000 shares $1.98 million +8.1%2.8%1.3 $1.94 1/15/2022943,500 shares $1.94 million -41.8%2.6%1.4 $2.06 12/31/20211,620,000 shares $6.24 million -10.0%4.4%2.8 $3.85 12/15/20211,800,000 shares $6.26 million -13.9%4.9%5 $3.48 11/30/20212,090,000 shares $8.03 million +8.9%5.7%5.9 $3.84 11/15/20211,920,000 shares $9.93 million -9.0%5.2%5.7 $5.17 10/29/20212,110,000 shares $11.86 million +6.0%5.6%6.1 $5.62 10/15/20211,990,000 shares $11.54 million -12.7%5.3%5.6 $5.80 9/30/20212,280,000 shares $12.72 million -32.9%6.1%6.2 $5.58 9/15/20213,400,000 shares $20.88 million -6.6%9.1%8.5 $6.14 8/31/20213,640,000 shares $24.24 million +3.7%9.8%9.8 $6.66 8/13/20213,510,000 shares $20.95 million -5.4%9.4%8.7 $5.97 7/30/20213,710,000 shares $27.31 million +3.3%10.1%9.3 $7.36 7/15/20213,590,000 shares $27.25 million +1.4%10.2%8.7 $7.59 6/30/20213,540,000 shares $31.47 million +6.0%10.0%8.2 $8.89 6/15/20213,340,000 shares $33.63 million -7.5%9.5%7.7 $10.07 5/28/20213,610,000 shares $32.45 million -4.2%10.2%7.5 $8.99 5/14/20213,770,000 shares $33.14 million -2.1%N/A6.1 $8.79 4/30/20213,850,000 shares $44.62 million -1.8%N/A5.3 $11.59 4/15/20213,920,000 shares $43.94 million -2.7%N/A5.7 $11.21 3/31/20214,030,000 shares $48.04 million +23.6%N/A5.9 $11.92 3/15/20213,260,000 shares $43.06 million -1.5%N/A5.1 $13.21 2/26/20213,310,000 shares $36.41 million +11.1%N/A5.8 $11.00 2/12/20212,980,000 shares $50.09 million +6.4%N/A5.6 $16.81 1/29/20212,800,000 shares $40.04 million +1.1%N/A7.5 $14.30 1/15/20212,770,000 shares $41.38 million -22.0%N/A8.3 $14.94 12/31/20203,550,000 shares $51.55 million +24.6%N/A11.4 $14.52 12/15/20202,850,000 shares $38.48 million -4.0%N/A9.3 $13.50 11/30/20202,970,000 shares $41.67 million -3.3%N/A10.4 $14.03 11/15/20203,070,000 shares $49.83 million +1.3%10.2%13 $16.23 10/30/20203,030,000 shares $45.24 million -2.6%10.1%17.1 $14.93 10/15/20203,110,000 shares $48.33 million -2.8%10.4%17 $15.54 9/30/20203,200,000 shares $41.66 million +14.3%10.7%16.9 $13.02 9/15/20202,800,000 shares $45.72 million +1.5%9.3%12.9 $16.33Trump’s Back, but DC’s Coming for Your Money! (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov 8/31/20202,760,000 shares $47.80 million -0.7%9.2%11.7 $17.32 8/14/20202,780,000 shares $46.93 million -3.8%9.3%9.7 $16.88 7/31/20202,890,000 shares $48.99 million +6.6%9.8%8.8 $16.95 7/15/20202,710,000 shares $48.73 million +12.5%9.3%8.1 $17.98 6/30/20202,410,000 shares $42.32 million +23.0%8.3%6.9 $17.56 6/15/20201,960,000 shares $40.28 million +13.3%6.7%5.7 $20.55 5/29/20201,730,000 shares $34.98 million +19.3%5.9%5 $20.22 5/15/20201,450,000 shares $22.59 million +8.2%5.0%4.2 $15.58 4/30/20201,340,000 shares $17.25 million -26.4%4.7%3.5 $12.87 4/15/20201,820,000 shares $24.39 million +18.2%6.4%4.9 $13.40 3/31/20201,540,000 shares $22.30 million -0.8%5.4%4.4 $14.48 3/13/20201,551,600 shares $21.69 million +6.3%11.7%6.4 $13.98 2/28/20201,460,000 shares $21.01 million -0.7%11.0%4.8 $14.39 2/14/20201,470,000 shares $27.47 million +53.6%6.8%5 $18.69 1/31/2020957,300 shares $17.46 million +35.5%4.3%4.4 $18.24 1/15/2020706,400 shares $19.22 million -56.1%3.2%3.9 $27.21 12/31/20191,610,000 shares $31.56 million -8.5%7.2%8.9 $19.60 AVRO Short Interest - Frequently Asked Questions What is AVROBIO's current short interest? Short interest is the volume of AVROBIO shares that have been sold short but have not yet been covered or closed out. As of May 31st, investors have sold 139,600 shares of AVRO short. 0.35% of AVROBIO's shares are currently sold short. Learn More on AVROBIO's current short interest. What is a good short interest ratio for AVROBIO? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVRO shares currently have a short interest ratio of 1.0. Learn More on AVROBIO's short interest ratio. What is a good short interest percentage for AVROBIO? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.35% of AVROBIO's floating shares are currently sold short. Is AVROBIO's short interest increasing or decreasing? AVROBIO saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 139,600 shares, a decrease of 23.1% from the previous total of 181,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is AVROBIO's float size? AVROBIO currently has issued a total of 44,890,000 shares. Some of AVROBIO's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AVROBIO currently has a public float of 39,430,000 shares. How does AVROBIO's short interest compare to its competitors? 0.35% of AVROBIO's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to AVROBIO: SOPHiA GENETICS SA (0.05%), Opthea Limited (0.13%), Compass Therapeutics, Inc. (2.09%), Atyr PHARMA INC (2.03%), Caribou Biosciences, Inc. (12.43%), Kodiak Sciences Inc. (2.67%), Solid Biosciences Inc. (4.40%), Inhibrx, Inc. (9.70%), Kyverna Therapeutics, Inc. (13.71%), Adaptimmune Therapeutics plc (2.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short AVROBIO stock? Short selling AVRO is an investing strategy that aims to generate trading profit from AVROBIO as its price is falling. AVRO shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AVROBIO? A short squeeze for AVROBIO occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AVRO, which in turn drives the price of the stock up even further. How often is AVROBIO's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVRO, twice per month. The most recent reporting period available is May, 31 2024. More Short Interest Resources from MarketBeat Related Companies SOPHiA GENETICS Short Squeeze Opthea Short Squeeze Compass Therapeutics Short Squeeze Atyr PHARMA Short Squeeze Caribou Biosciences Short Squeeze Kodiak Sciences Short Squeeze Solid Biosciences Short Squeeze Inhibrx Short Squeeze Kyverna Therapeutics Short Squeeze Adaptimmune Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVRO) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVROBIO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVROBIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.